Lineage Cell Therapeutics (LCTX) Receivables - Other (2011 - 2026)
Lineage Cell Therapeutics' (LCTX) quarterly Receivables - Other came in at $585000.0 in Q1 2026, down 12.82% quarter-over-quarter from $671000.0 in Q4 2025.
Lineage Cell Therapeutics (LCTX) Receivables - Other (2011 - 2026) Analysis & Trends
Lineage Cell Therapeutics' Receivables - Other history runs 10 years deep, the most recent figure standing at $585000.0 for Q1 2026.
- On a quarterly basis, Receivables - Other changed N/A year-over-year to $585000.0 in Q1 2026; TTM through Mar 2026 was $585000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $671000.0, changed N/A from the prior year.
- Receivables - Other eased to $585000.0 in Q1 2026 per LCTX's latest filing, from $671000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $671000.0 in Q4 2025 and bottomed at $545000.0 in Q3 2022.
- The 3-year median for Receivables - Other is $581000.0 (2022), against an average of $586200.0.
- Biggest YoY gain for Receivables - Other was 8.6% in 2022; the steepest drop was 8.6% in 2022.
- Year by year, Receivables - Other stood at $581000.0 in 2022, then advanced by 15.49% to $671000.0 in 2025, then decreased by 12.82% to $585000.0 in 2026.
- Per Business Quant, the three latest LCTX Receivables - Other figures stand at $585000.0 (Q1 2026), $671000.0 (Q4 2025), and $549000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Lineage Cell Therapeutics | 267.08 Mn | 203.18 Mn | 1.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 585,000.00 |
| Mar 31, 2026 | 585,000.00 |
| Dec 31, 2025 | 671,000.00 |
| Dec 31, 2025 | 671,000.00 |
| Sep 30, 2025 | 549,000.00 |
| Sep 30, 2025 | 549,000.00 |
| Dec 31, 2022 | 581,000.00 |
| Dec 31, 2022 | 581,000.00 |
| Sep 30, 2022 | 545,000.00 |
| Sep 30, 2022 | 545,000.00 |
| Dec 31, 2021 | 535,000.00 |
| Dec 31, 2021 | 535,000.00 |
| Jun 30, 2020 | 7,000.00 |
| Jun 30, 2020 | 7,000.00 |
| Mar 31, 2020 | 47,000.00 |
| Mar 31, 2020 | 47,000.00 |
| Dec 31, 2019 | 7,000.00 |
| Dec 31, 2019 | 7,000.00 |
| Sep 30, 2019 | 164,000.00 |
| Sep 30, 2019 | 164,000.00 |